Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
Research output: Contribution to journal › Journal article › peer-review
Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.
Original language | English |
---|---|
Journal | Journal of Internal Medicine |
Volume | 268 |
Issue number | 3 |
Pages (from-to) | 296-308 |
Number of pages | 13 |
ISSN | 0954-6820 |
DOIs | |
Publication status | Published - 2010 |
ID: 33248879